EXPRESSION OF MEMBRANE TYPE-2 AND -3 MATRIX METALLOPROTEINASES IN EUTOPIC ENDOMETRIUM OF WOMEN WITH ADVANCED ENDOMETRIOSIS
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective To investigate the expression of messenger RNA (mRNA) for membrane type-2 matrix metalloproteinases (MT2-MMPs ) and MT3-MMP and compare their expression pattern in women with severe endometriosis and normal controls. Methods Quantitative competitive polymerase chain reaction was performed to evaluate the mRNA expression of MT2-MMP and MT3-MMP in endometrium from 36 women with severe endometriosis and 52 women without endometriosis throughout the menstrual cycle. Results Eutopic endometrium from women with endometriosis expressed higher levels of MT3-MMP than that from normal women in secretory phase (P < 0.05). MT2-MMP expression from eutopic endometrium showed no signifi cant differences between patients with endometriosis and controls. Conclusion These results suggest that eutopic endometrium from patients with endometriosis may be more proteolytic, angiogenic and prone to growth because of greater MT3-MMP expression than endometrium from women without endometriosis. Thus, increased proteolytic and angiogenic activities may be one of the explanations of the pathogenesis of endometriosis.
Abstract
Objective To investigate the expression of messenger RNA (mRNA) for membrane type-2 matrix metalloproteinases (MT2-MMPs ) and MT3-MMP and compare their expression pattern in women with severe endometriosis and normal controls. Methods Quantitative competitive polymerase chain reaction was performed to evaluate the mRNA expression of MT2-MMP and MT3-MMP in endometrium from 36 women with severe endometriosis and 52 women without endometriosis throughout the menstrual cycle. Results Eutopic endometrium from women with endometriosis expressed higher levels of MT3-MMP than that from normal women in secretory phase (P < 0.05). MT2-MMP expression from eutopic endometrium showed no signifi cant differences between patients with endometriosis and controls. Conclusion These results suggest that eutopic endometrium from patients with endometriosis may be more proteolytic, angiogenic and prone to growth because of greater MT3-MMP expression than endometrium from women without endometriosis. Thus, increased proteolytic and angiogenic activities may be one of the explanations of the pathogenesis of endometriosis.
참고문헌 (39)
- Lamb K, "Family trait analysis: a case-control study of 43 women with endometriosis and their best friends", Am J Obstet Gynecol, 154, pp.596~601 (1986)
- Cramer DW, "The relation of endometriosis to menstrual characteristics, smoking, and exercise", JAMA, 255, pp.1904~1908 (1986)
- Ramey JW, "Peritoneal fl uid: its relevance to the development of endometriosis", Fertil Steril, 60, pp.1~14 (1993)
- Oosterlynck DJ, "Angiogenic activity of peritoneal fl uid from women with endometriosis", Fertil Steril, 59, pp.778~782 (1993)
- Sampson JA, "Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation", Am J Pathol, 3, pp.93~110 (1927)
- Heymans S, "Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure", Nat Med, 5, pp.1135~1142 (1999)
- Stetler-Stevenson WG, "Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention", J Clin Invest, 103, pp.1237~1241 (1999)
- Pepper MS, "Extracellular proteolysis and angiogenesis", Thromb Haemost, 86, pp.346~355 (2001)
- MacDougall JR, "Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis", Cancer Metastasis Rev, 14, pp.351~362 (1995)
- Hotary K, "Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3", Cell Biol, 149, pp.1309~1323 (2000)
- Visse R, "Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry", Circ Res, 92, pp.827~839 (2003)
- Hotary KB, "Matrix metalloproteinases (MMPs) regulate fi brininvasive activity via MT1-MMP-dependent and -independent processes", J Exp Med, 195, pp.295~308 (2002)
- Zhou Z, "Impaired endochondral ossifi cation and angiogenesis in mice defi cient in membrane-type matrix metalloproteinase I", Proc Natl Acad Sci U S A, 97, pp.4052~4057 (2000)
- Sounni NE, "MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression", FASEB J, 16, pp.555~564 (2002)
- Seiki M, "Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis", Cancer Sci, 94, pp.569~574 (2003)
- Chung HW, "Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium", Fertil Steril, 78, pp.787~795 (2002)
- Goffi n F, "Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium", Biol Reprod, 69, pp.976~984 (2003)
- Määttä M, "Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation", Am J Clin Pathol, 114, pp.402~411 (2000)
- Zhang J, "Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium", Biol Reprod, 62, pp.85~94 (2000)
- Plaisier M, "Membrane-type matrix metalloproteinases and vascularization in human endometrium during the menstrual cycle", Mol Hum Reprod, 12, pp.11~18 (2006)
- Collette T, "Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9", Hum Reprod, 19, pp.1257~1264 (2004)
- "Revised American Fertility Society classifi cation of endometriosis: 1985", Fertil Steril, 43, pp.351~352 (1985)
- Noyes RW, "Dating the endometrial biopsy", Fertil Steril, 1, pp.3~25 (1950)
- Sato H, "A matrix metalloproteinase expressed on the surface of invasive tumour cells", Nature, 370, pp.61~65 (1994)
- Takino T, "Identifi cation of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family", J Biol Chem, 270, pp.23013~23020 (1995)
- Will H, "cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment", Eur J Biochem, 231, pp.602~608 (1995)
- Puente XS, "Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma", Cancer Res, 56, pp.944~949 (1996)
- Pei D, "Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP", J Biol Chem, 274, pp.8925~8932 (1999)
- Kolkenbrock H, "Activation of progelatinase A and progelatinase A", TIMP-2 complex by membrane type 2-matrix metalloproteinase, 1997, pp.378, 71~76
- Atkinson SJ, "Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes", J Biol Chem, 270, pp.30479~30485 (1995)
- Knäuper V, "Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme", J Biol Chem, 271, pp.17124~17131 (1996)
- Okada A, "Membrane-type matrix metalloproteinase (MT MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas", Proc Natl Acad Sci U S A, 92, pp.2730~2734 (1995)
- Velasco G, "Human MT6-matrix metalloproteinase: identifi cation, progelatinase A activation, and expression in brain tumors", Cancer Res, 60, pp.877~882 (2000)
- Crawford HC, "Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression", Invasion Metastasis, 14, pp.234~245 (1994)
- Ueno H, "Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas", Cancer Res, 57, pp.2055~2060 (1997)
- Gilles C, "High level of MT-MMP expression is associated with invasiveness of cervical cancer cells", Int J Cancer, 65, pp.209~213 (1996)
- Kitagawa Y, "Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas", J Urol, 160, pp.1540~1545 (1998)
- Pap T, "Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis", Arthritis Rheum, 43, pp.1226~1232 (2000)
- Davidson B, "Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions", Am J Clin Pathol, 115, pp.517~524 (2001)
